Form 4: Alnylam Pharmaceuticals Executive Pushkal Garg Reports Stock Sales Following RSU Vesting
SEC Form 4 Filing
Pushkal Garg, CMO & EVP of Development & Medical Affairs at Alnylam Pharmaceuticals, reports the sale of company stock to cover tax obligations after restricted stock units vested.
Summary
- Pushkal Garg, CMO & EVP of Development & Medical Affairs at Alnylam Pharmaceuticals, filed a Form 4 disclosing transactions related to company stock.
- On February 27, 2024, 1,908 restricted stock units (RSUs) vested, converting into common stock.
- To cover statutory tax withholding obligations, 1,908 shares were sold automatically by the company on Garg's behalf.
- Additionally, between February 28, 2024, a total of 574 shares were sold in multiple transactions at weighted average prices ranging from $154.54 to $158.09.
- Following these transactions, Garg directly owns 8,666 shares of Alnylam common stock.
- Garg also indirectly owns 431 shares through a managed account and 250 shares through a trust where his spouse is co-trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future stock performance.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 02/27/2023 | Reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. |
| 02/27/2024 | 1,908 restricted stock units vested and were released. |
| 02/28/2024 | Shares of common stock were sold. |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.